Aflibercept (EYLEA) Anti-VEGF Intravitreal Injection
Aflibercept (Eylea) anti-VEGF intravitreal injection is used to treat retinal diseases causing vision loss by reducing leakage and abnormal blood vessel growth.
- The description claims that it helps stabilize or improve vision in conditions like wet macular degeneration and diabetic macular edema.
AI Readiness
Good foundation, but some important product data is still missing.
66%